Oxidative Stress and Inflammation Are Differentially Affected by Atorvastatin, Pravastatin, Rosuvastatin, and Simvastatin on Lungs from Mice Exposed to Cigarette Smoke

Inflammation

Volumn 37, Issue 5, 2014, Pages 1355-1365

  Ferreira, Thiago Santos ^a   Lanzetti, Manuella ^b   Barroso, Marina Valente ^a   Rueff Barroso, Carlos Romualdo ^b   Benjamim, Cláudia Farias ^a   de Brito Gitirana, Lycia ^a   Porto, Luís Cristóvão ^b   Valença, Samuel Santos ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

cigarette smoke; inflammation; lung; mice; oxidative stress; statins

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; ATORVASTATIN; CATALASE; CIGARETTE SMOKE; GLUTATHIONE; GLUTATHIONE DISULFIDE; HYDROGEN PEROXIDE; KERATINOCYTE DERIVED CHEMOKINE; LIPID HYDROPEROXIDE; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOPEROXIDASE; NITRIC OXIDE; NITRITE; PRAVASTATIN; REACTIVE OXYGEN METABOLITE; ROSUVASTATIN; SIMVASTATIN; SUPEROXIDE DISMUTASE; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; AUTACOID; FLUOROBENZENE; HEPTANOIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PYRIMIDINE DERIVATIVE; PYRROLE DERIVATIVE; SULFONAMIDE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; EXPOSURE; LEUKOCYTE; LUNG HOMOGENATE; LUNG LAVAGE; LUNG PARENCHYMA; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PNEUMONIA; PROTEIN EXPRESSION; SMOKING; ADVERSE EFFECTS; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; DRUG EFFECTS; DRUG THERAPY; LUNG; METABOLISM; PATHOLOGY; PHYSIOLOGY;

MUS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; FLUOROBENZENES; HEPTANOIC ACIDS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INFLAMMATION MEDIATORS; INHALATION EXPOSURE; LUNG; MALE; MICE; MICE, INBRED C57BL; OXIDATIVE STRESS; PRAVASTATIN; PYRIMIDINES; PYRROLES; SIMVASTATIN; SMOKING; SULFONAMIDES;

EID: 84918793005     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-014-9860-y     Document Type: Article

References (80)

1. Brody, J.S., and A. Spira. 2006. State of the art. Chronic obstructive pulmonary disease, inflammation, and lung cancer. Proceedings of the American Thoracic Society 3: 535–7.
2. Sapey, E., and R.A. Stockley. 2006. COPD exacerbations. 2: aetiology. Thorax 61: 250–8.
3. Musk, A.W., and N.H. de Klerk. 2003. History of tobacco and health. Respirology 8: 286–90.
4. Takahashi, S., H. Nakamura, M. Seki, Y. Shiraishi, M. Yamamoto, M. Furuuchi, et al. 2008. Reversal of elastase-induced pulmonary emphysema and promotion of alveolar epithelial cell proliferation by simvastatin in mice. American Journal of Physiology. Lung Cellular and Molecular Physiology 294: L882–90.
5. Groneberg, D.A., and K.F. Chung. 2004. Models of chronic obstructive pulmonary disease. Respiratory Research 5: 18.
6. Lapperre, T.S., J.K. Sont, A. van Schadewijk, M.M. Gosman, D.S. Postma, I.M. Bajema, et al. 2007. Smoking cessation and bronchial epithelial remodelling in COPD: a cross-sectional study. Respiratory Research 8: 85.
7. Pryor, W.A., and K. Stone. 1993. Oxidants in cigarette smoke. Radicals, hydrogen peroxide, peroxynitrate, and peroxynitrite. Annals of the New York Academy of Sciences 686: 12–27. discussion 27-8.
8. Spurzem, J.R., and S.I. Rennard. 2005. Pathogenesis of COPD. Seminars in Respiratory and Critical Care Medicine 26: 142–53.
9. Lanzetti, M., F.S. Bezerra, B. Romana-Souza, A.C. Brando-Lima, V.L. Koatz, L.C. Porto, et al. 2008. Mate tea reduced acute lung inflammation in mice exposed to cigarette smoke. Nutrition 24: 375–81.
10. Rahman, I., and I.M. Adcock. 2006. Oxidative stress and redox regulation of lung inflammation in COPD. European Respiratory Journal 28: 219–42.
11. Valenca, S.S., W.A. Pimenta, C.R. Rueff-Barroso, T.S. Ferreira, A.C. Resende, R.S. Moura, et al. 2009. Involvement of nitric oxide in acute lung inflammation induced by cigarette smoke in the mouse. Nitric Oxide 20: 175–81.
12. Helen, A., and P.L. Vijayammal. 1997. Effect of vitamin A supplementation on cigarette smoke-induced lipid peroxidation. Veterinary and Human Toxicology 39: 18–21.
13. Bar-Shai, M., E. Hasnis, Z. Wiener-Megnazi, and A.Z. Reznick. 2006. The role of reactive nitrogen species and cigarette smoke in activation of transcription factor NF-kappaB and implication to inflammatory processes. Journal of Physiology and Pharmacology 57(Suppl 4): 39–44.
14. Maron, D.J., S. Fazio, and M.F. Linton. 2000. Current perspectives on statins. Circulation 101: 207–13.
15. Jacobson, J.R., J.W. Barnard, D.N. Grigoryev, S.F. Ma, R.M. Tuder, and J.G. Garcia. 2005. Simvastatin attenuates vascular leak and inflammation in murine inflammatory lung injury. American Journal of Physiology. Lung Cellular and Molecular Physiology 288: L1026–32.
16. Morikawa, S., W. Takabe, C. Mataki, T. Kanke, T. Itoh, Y. Wada, et al. 2002. The effect of statins on mRNA levels of genes related to inflammation, coagulation, and vascular constriction in HUVEC. Human umbilical vein endothelial cells. Journal of Atherosclerosis and Thrombosis 9: 178–83.
17. Sezer, E.D., E.Y. Sozmen, D. Nart, and T. Onat. 2011. Effect of atorvastatin therapy on oxidant-antioxidant status and atherosclerotic plaque formation. Vascular Health and Risk Management 7: 333–43.
18. Heeba, G., M.E. Moselhy, M. Hassan, M. Khalifa, R. Gryglewski, and T. Malinski. 2009. Anti-atherogenic effect of statins: role of nitric oxide, peroxynitrite and haem oxygenase-1. British Journal of Pharmacology 156: 1256–66.
19. Moura, R.S., T.S. Ferreira, A.A. Lopes, K.M. Pires, R.T. Nesi, A.C. Resende, et al. 2012. Effects of Euterpe oleracea Mart. (ACAI) extract in acute lung inflammation induced by cigarette smoke in the mouse. Phytomedicine 19: 262–9.
20. Pires, K.M., S.S. Valenca, A.C. Resende, L.C. Porto, E.F. Queiroz, D.D. Moreira, et al. 2011. Grape skin extract reduced pulmonary oxidative response in mice exposed to cigarette smoke. Medical Science Monitor 17: BR187–195.
21. Silva Bezerra, F., S.S. Valenca, M. Lanzetti, W.A. Pimenta, P. Castro, V.L. Goncalves Koatz, et al. 2006. Alpha-tocopherol and ascorbic acid supplementation reduced acute lung inflammatory response by cigarette smoke in mouse. Nutrition 22: 1192–201.
22. Valenca, S.S., F. Silva Bezerra, A.A. Lopes, B. Romana-Souza, M.C. Marinho Cavalcante, A.B. Lima, et al. 2008. Oxidative stress in mouse plasma and lungs induced by cigarette smoke and lipopolysaccharide. Environmental Research 108: 199–204.
23. Rakotoniaina, Z., P. Guerard, F. Lirussi, F. Goirand, L. Rochette, M. Dumas, et al. 2006. The protective effect of HMG-CoA reductase inhibitors against monocrotaline-induced pulmonary hypertension in the rat might not be a class effect: comparison of pravastatin and atorvastatin. Naunyn-Schmiedeberg's Archives of Pharmacology 374: 195–206.
24. Yao, H.W., L.G. Mao, and J.P. Zhu. 2006. Protective effects of pravastatin in murine lipopolysaccharide-induced acute lung injury. Clinical and Experimental Pharmacology and Physiology 33: 793–7.
25. Zaitone, S.A., and N.M. Abo-Gresha. 2012. Rosuvastatin promotes angiogenesis and reverses isoproterenol-induced acute myocardial infarction in rats: role of iNOS and VEGF. European Journal of Pharmacology 691: 134–42.
26. Muller, H.C., K. Hellwig, S. Rosseau, T. Tschernig, A. Schmiedl, B. Gutbier, et al. 2010. Simvastatin attenuates ventilator-induced lung injury in mice. Critical Care 14: R143.
27. Suzuki, K., H. Ota, S. Sasagawa, T. Sakatani, and T. Fujikura. 1983. Assay method for myeloperoxidase in human polymorphonuclear leukocytes. Analytical Biochemistry 132: 345–52.
28. Green, L.C., D.A. Wagner, J. Glogowski, P.L. Skipper, J.S. Wishnok, and S.R. Tannenbaum. 1982. Analysis of nitrate, nitrite, and [15 N]nitrate in biological fluids. Analytical Biochemistry 126: 131–8.
29. Kerkweg, U., F. Petrat, H.G. Korth, and H. de Groot. 2007. Disruption of skeletal myocytes initiates superoxide release: contribution of NADPH oxidase. Shock 27: 552–8.
30. Bannister, J.V., and L. Calabrese. 1987. Assays for superoxide dismutase. Methods of Biochemical Analysis 32: 279–312.
31. Aebi, H. 1984. Catalase in vitro. Methods Enzymol 105: 121–6.
32. Rahman, I., A. Kode, and S.K. Biswas. 2006. Assay for quantitative determination of glutathione and glutathione disulfide levels using enzymatic recycling method. Nature Protocols 1: 3159–65.
33. Kovala-Demertzi, D., D. Hadjipavlou-Litina, A. Primikiri, M. Staninska, C. Kotoglou, and M.A. Demertzis. 2009. Anti-inflammatory, antiproliferative, and radical-scavenging activities of tolfenamic acid and its metal complexes. Chemistry and Biodiversity 6: 948–60.
34. Hermes-Lima, M., W.G. Willmore, and K.B. Storey. 1995. Quantification of lipid peroxidation in tissue extracts based on Fe(III)xylenol orange complex formation. Free Radical Biology and Medicine 19: 271–80.
35. Kim, D.Y., S.Y. Ryu, J.E. Lim, Y.S. Lee, and J.Y. Ro. 2007. Anti-inflammatory mechanism of simvastatin in mouse allergic asthma model. European Journal of Pharmacology 557: 76–86.
36. Wang, C.Y., P.Y. Liu, and J.K. Liao. 2008. Pleiotropic effects of statin therapy: molecular mechanisms and clinical results. Trends in Molecular Medicine 14: 37–44.
37. Wright, J.L., S. Zhou, O. Preobrazhenska, C. Marshall, D.D. Sin, I. Laher, et al. 2011. Statin reverses smoke-induced pulmonary hypertension and prevents emphysema but not airway remodeling. American Journal of Respiratory and Critical Care Medicine 183: 50–8.
38. Rise, P., S. Ghezzi, C. Manzoni, C. Colombo, and C. Galli. 2009. The in vitro effects of cigarette smoke on fatty acid metabolism are partially counteracted by simvastatin. Prostaglandins, Leukotrienes, and Essential Fatty Acids 80: 71–5.
39. Rose Jr., C.E., S.S. Sung, and S.M. Fu. 2003. Significant involvement of CCL2 (MCP-1) in inflammatory disorders of the lung. Microcirculation 10: 273–88.
40. Fildes, J.E., S.M. Shaw, A. Mitsidou, K. Rogacev, C.T. Leonard, S.G. Williams, et al. 2008. HMG-CoA reductase inhibitors deplete circulating classical and non-classical monocytes following human heart transplantation. Transplant Immunology 19: 152–7.
41. Teupser, D., M. Bruegel, O. Stein, Y. Stein, and J. Thiery. 2001. HMG-CoA reductase inhibitors reduce adhesion of human monocytes to endothelial cells. Biochemical and Biophysical Research Communications 289: 838–44.
42. Montecucco, F., F. Burger, G. Pelli, N.K. Poku, C. Berlier, S. Steffens, et al. 2009. Statins inhibit C-reactive protein-induced chemokine secretion, ICAM-1 upregulation and chemotaxis in adherent human monocytes. Rheumatology (Oxford) 48: 233–42.
43. Konrad FM, Reutershan J. 2012. CXCR2 in acute lung injury. Mediators Inflammation doi:10.1155/2012/740987
44. Togbe, D., S. Schnyder-Candrian, B. Schnyder, E. Doz, N. Noulin, L. Janot, et al. 2007. Toll-like receptor and tumour necrosis factor dependent endotoxin-induced acute lung injury. International Journal of Experimental Pathology 88: 387–91.
45. McDonald, P.P., S.R. McColl, P.H. Naccache, and P. Borgeat. 1992. Activation of the human neutrophil 5-lipoxygenase by leukotriene B4. British Journal of Pharmacology 107: 226–32.
46. Sadik, C.D., N.D. Kim, and A.D. Luster. 2011. Neutrophils cascading their way to inflammation. Trends in Immunology 32: 452–60.
47. Lysgaard, C., M.S. Nielsen, J.H. Christensen, S. Lundbye-Christensen, S. Riahi, and E.B. Schmidt. 2012. No effect of high-dose atorvastatin on leukotriene B(4) formation from neutrophils in patients treated with coronary bypass surgery: a randomized placebo-controlled double-blinded trial with a crossover design. Prostaglandins, Leukotrienes, and Essential Fatty Acids 87: 185–8.
48. Chen, L.W., C.M. Hsu, J.S. Wang, H.L. Chen, and J.S. Chen. 2001. Inhibition of inducible nitric oxide synthase (iNOS) prevents lung neutrophil deposition and damage in burned rats. Shock 15: 151–6.
49. Gabbay, E., E. Haydn Walters, B. Orsida, H. Whitford, C. Ward, T.C. Kotsimbos, et al. 1999. In stable lung transplant recipients, exhaled nitric oxide levels positively correlate with airway neutrophilia and bronchial epithelial iNOS. American Journal of Respiratory and Critical Care Medicine 160: 2093–9.
50. Harkin, D.W., B.B. Rubin, A. Romaschin, and T.F. Lindsay. 2004. Selective inducible nitric oxide synthase (iNOS) inhibition attenuates remote acute lung injury in a model of ruptured abdominal aortic aneurysm. Journal of Surgical Research 120: 230–41.
51. Igawa, S., I. Hayashi, N. Tanaka, H. Hiruma, M. Majima, T. Kawakami, et al. 2004. Nitric oxide generated by iNOS reduces deformability of Lewis lung carcinoma cells. Cancer Science 95: 342–7.
52. Wang, L.F., S. Mehta, S. Weicker, J.A. Scott, M. Joseph, H.M. Razavi, et al. 2001. Relative contribution of hemopoietic and pulmonary parenchymal cells to lung inducible nitric oxide synthase (inos) activity in murine endotoxemia. Biochemical and Biophysical Research Communications 283: 694–9.
53. Zhao, H., J.K. Ma, M.W. Barger, R.R. Mercer, L. Millecchia, D. Schwegler-Berry, et al. 2009. Reactive oxygen species- and nitric oxide-mediated lung inflammation and mitochondrial dysfunction in wild-type and iNOS-deficient mice exposed to diesel exhaust particles. Journal of Toxicology and Environmental Health A 72: 560–70.
54. Dodd, O.J., and D.B. Pearse. 2000. Effect of the NADPH oxidase inhibitor apocynin on ischemia-reperfusion lung injury. American Journal of Physiology. Heart and Circulatory Physiology 279: H303–12.
55. Segal, B.H., B.A. Davidson, A.D. Hutson, T.A. Russo, B.A. Holm, B. Mullan, et al. 2007. Acid aspiration-induced lung inflammation and injury are exacerbated in NADPH oxidase-deficient mice. American Journal of Physiology. Lung Cellular and Molecular Physiology 292: L760–8.
56. Xiang, M., L. Yin, Y. Li, G. Xiao, Y. Vodovotz, T.R. Billiar, et al. 2011. Hemorrhagic shock activates lung endothelial reduced nicotinamide adenine dinucleotide phosphate (NADPH) oxidase via neutrophil NADPH oxidase. American Journal of Respiratory Cell and Molecular Biology 44: 333–40.
57. Terblanche, M., Y. Almog, R.S. Rosenson, T.S. Smith, and D.G. Hackam. 2007. Statins and sepsis: multiple modifications at multiple levels. Lancet Infectious Diseases 7: 358–68.
58. Chen, W., S. Pendyala, V. Natarajan, J.G. Garcia, and J.R. Jacobson. 2008. Endothelial cell barrier protection by simvastatin: GTPase regulation and NADPH oxidase inhibition. American Journal of Physiology Lung Cellular and Molecular Physiology 295: L575–83.
59. Bargagli, E., C. Olivieri, D. Bennett, A. Prasse, J. Muller-Quernheim, and P. Rottoli. 2009. Oxidative stress in the pathogenesis of diffuse lung diseases: a review. Respiratory Medicine 103: 1245–56.
60. Bast, A., A.R. Weseler, G.R. Haenen, and G.J. den Hartog. 2010. Oxidative stress and antioxidants in interstitial lung disease. Current Opinion in Pulmonary Medicine 16: 516–20.
61. Ward, P.A. 2010. Oxidative stress: acute and progressive lung injury. Annals of the New York Academy of Sciences 1203: 53–9.
62. Chow, C.K. 1993. Cigarette smoking and oxidative damage in the lung. Annals of the New York Academy of Sciences 686: 289–98.
63. Paz-Elizur, T., M. Krupsky, D. Elinger, E. Schechtman, and Z. Livneh. 2005. Repair of the oxidative DNA damage 8-oxoguanine as a biomarker for lung cancer risk. Cancer Biomarkers 1: 201–5.
64. Al-Shabrawey, M., M. Bartoli, A.B. El-Remessy, G. Ma, S. Matragoon, T. Lemtalsi, et al. 2008. Role of NADPH oxidase and Stat3 in statin-mediated protection against diabetic retinopathy. Investigative Ophthalmology & Visual Science 49: 3231–8.
65. Antoniades, C., M. Demosthenous, S. Reilly, M. Margaritis, M.H. Zhang, A. Antonopoulos, et al. 2012. Myocardial redox state predicts in-hospital clinical outcome after cardiac surgery effects of short-term pre-operative statin treatment. Journal of the American College of Cardiology 59: 60–70.
66. Bartoli, M., M. Al-Shabrawey, M. Labazi, M.A. Behzadian, M. Istanboli, A.B. El-Remessy, et al. 2009. HMG-CoA reductase inhibitors (statin) prevents retinal neovascularization in a model of oxygen-induced retinopathy. Investigative Ophthalmology & Visual Science 50: 4934–40.
67. Key, P.B., J. Hoguet, L.A. Reed, K.W. Chung, and M.H. Fulton. 2008. Effects of the statin antihyperlipidemic agent simvastatin on grass shrimp, Palaemonetes pugio. Environmental Toxicology 23: 153–60.
68. Riad, A., S. Bien, D. Westermann, P.M. Becher, K. Loya, U. Landmesser, et al. 2009. Pretreatment with statin attenuates the cardiotoxicity of doxorubicin in mice. Cancer Research 69: 695–9.
69. da Silva, P.M. 2011. Are all statins the same? Focus on the efficacy and tolerability of pitavastatin. American Journal of Cardiovascular Drugs 11: 93–107.
70. Ohshima, K., M. Mogi, H. Nakaoka, F. Jing, J. Iwanami, L.J. Min, et al. 2012. Inhibition of MCP-1/CCR2 signaling pathway is involved in synergistic inhibitory effects of irbesartan with rosuvastatin on vascular remodeling. Journal of the American Society of Hypertension 6: 375–84.
71. Sultana, C., Y. Shen, V. Rattan, and V.K. Kalra. 1996. Lipoxygenase metabolites induced expression of adhesion molecules and transendothelial migration of monocyte-like HL-60 cells is linked to protein kinase C activation. Journal of Cellular Physiology 167: 477–87.
72. Belli, S., O. Basaran, B.H. Ozdemir, S. Turkoglu, G. Karabay, A. Kut, et al. 2011. Protective role of simvastatin on lung damage caused by burn and cotton smoke inhalation in rats. Journal of Surgical Research 167: e283–90.
73. Al-Otaibi KE, Al Elaiwi AM, Tariq M, Al-Asmari AK. 2012. Simvastatin attenuates contrast-induced nephropathy through modulation of oxidative stress, proinflammatory myeloperoxidase, and nitric oxide. Oxidative Medicine and Cellular Longevity doi:10.1155/2012/831748
74. Gill, L., J. Santa, D.L. Peter, and J. Keehn. 2012. Lipitor goes generic: business as usual or more big business? Annals of Internal Medicine 156: 892–3. W313.
75. Bezerra, F.S., S.S. Valenca, K.M. Pires, M. Lanzetti, W.A. Pimenta, A.C. Schmidt, et al. 2011. Long-term exposure to cigarette smoke impairs lung function and increases HMGB-1 expression in mice. Respiratory Physiology & Neurobiology 177: 120–6.
76. da Hora, K., S.S. Valenca, and L.C. Porto. 2005. Immunohistochemical study of tumor necrosis factor-alpha, matrix metalloproteinase-12, and tissue inhibitor of metalloproteinase-2 on alveolar macrophages of BALB/c mice exposed to short-term cigarette smoke. Experimental Lung Research 31: 759–70.
77. de Moura, R.S., K.M. Pires, T. Santos Ferreira, A.A. Lopes, R.T. Nesi, A.C. Resende, et al. 2011. Addition of acai (Euterpe oleracea) to cigarettes has a protective effect against emphysema in mice. Food and Chemical Toxicology 49: 855–63.
78. Valenca, S.S., K. da Hora, P. Castro, V.G. Moraes, L. Carvalho, and L.C. Porto. 2004. Emphysema and metalloelastase expression in mouse lung induced by cigarette smoke. Toxicologic Pathology 32: 351–6.
79. Valenca, S.S., and L.C. Porto. 2008. Immunohistochemical study of lung remodeling in mice exposed to cigarette smoke*. Jornal Brasileiro de Pneumologia 34: 787–95.
80. Valenca, S.S., C.R. Rueff-Barroso, W.A. Pimenta, A.C. Melo, R.T. Nesi, M.A. Silva, et al. 2011. L-NAME and l-arginine differentially ameliorate cigarette smoke-induced emphysema in mice. Pulmonary Pharmacology & Therapeutics 24: 587–94.